Vanguard Global Advisers’s Health Catalyst HCAT Stock Holding History
Bought
Maintained
Sold
Other funds holding HCAT
CF
MBAM
Vanguard Global Advisers's HCAT Position: Q3 2026 in Review
Vanguard Global Advisers reduced its Health Catalyst (HCAT) stake by 49% in Q3 2026, selling an estimated $33.7K and leaving 18,036 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #3225.
Vanguard Global Advisers first reported a position in HCAT in Q1 2026 and has held it in 3 quarters since. The position peaked at $220K in Q1 2026. 109 funds tracked by Wall St. Rank hold HCAT as of Q3 2026.
- Vanguard Global Advisers held 18,036 shares of Health Catalyst worth $31.2K as of Q3 2026.
- Vanguard Global Advisers sold 17,647 Health Catalyst shares in Q3 2026, an estimated $33.7K.
- Health Catalyst made up ﹤0.01% of Vanguard Global Advisers's portfolio in Q3 2026, its #3225 holding.
- Vanguard Global Advisers first reported a position in Health Catalyst in Q1 2026 and has held it in 3 quarters since.
- Vanguard Global Advisers's Health Catalyst position peaked at $220K in Q1 2026.
- 109 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2026.
Based on Vanguard Global Advisers's 13F filing for Q3 2026, filed 13 Nov 2026.